Postprandial hypertriglyceridemia and cardiovascular disease: current and future therapies.
about
Origin and therapy for hypertriglyceridaemia in type 2 diabetesThe ER-associated degradation adaptor protein Sel1L regulates LPL secretion and lipid metabolismPlasma lipoprotein(a) levels are associated with mild renal impairment in type 2 diabetics independent of albuminuria.Postprandial effects of polydextrose on satiety hormone responses and subjective feelings of appetite in obese participants.Taste hedonics influence the disposition of fat by modulating gastric emptying in ratsPhenotypic flexibility as key factor in the human nutrition and health relationship.Identification of a botanical inhibitor of intestinal diacylglyceride acyltransferase 1 activity via in vitro screening and a parallel, randomized, blinded, placebo-controlled clinical trial.Postprandial Inflammatory Responses and Free Fatty Acids in Plasma of Adults Who Consumed a Moderately High-Fat Breakfast with and without Blueberry Powder in a Randomized Placebo-Controlled Trial.Resistance Exercise Attenuates High-Fructose, High-Fat-Induced Postprandial Lipemia.Postprandial Hyperlipidemia and Remnant Lipoproteins.Postprandial Dysmetabolism and Oxidative Stress in Type 2 Diabetes: Pathogenetic Mechanisms and Therapeutic Strategies.Postprandial dietary fatty acids exert divergent inflammatory responses in retinal-pigmented epithelium cells.Triglyceride Treatment in the Age of Cholesterol Reduction.Nutrition, inflammation and liver-spleen axis.The Influence of Pre-Exercise Glucose versus Fructose Ingestion on Subsequent Postprandial Lipemia.Metabolic phenotypes of obesity influence triglyceride and inflammation homoeostasis.Acute effects of dietary fatty acids on osteclastogenesis via RANKL/RANK/OPG system.High-Intensity Intermittent Exercise Increases Fat Oxidation Rate and Reduces Postprandial Triglyceride Concentrations.
P2860
Q26824004-3C8D051A-BCF3-469E-8371-800309B1D737Q28594858-A3246A95-E185-47FE-B291-21C9780BDB6DQ34662899-D122AB3A-CBC5-4820-AE98-30F3E4703D10Q35060088-342D5E32-CA92-43CD-9E9C-803D166E4AD4Q35111387-0BE548ED-8DD7-4645-BD8D-2688062432B2Q35222025-01485CB1-5AA2-43DB-A052-5DBCAE477F7EQ35738483-B467A207-B2B5-4EBC-A0FE-F9C8A6299C4DQ36053581-06F54EE9-E74B-44D7-A67F-F3A6A69DAE93Q36170383-45AE2389-C205-444E-B62F-21E0C41D9BCFQ37639159-3CF653BB-4316-4405-BB7C-4EBE431CA522Q38460480-1C838545-FBE3-4FDB-BE60-2254FDCA3403Q38791137-F8E252A8-5B58-453C-AB86-9BA447D064AFQ38932760-E22111A0-C3BD-41AE-B91F-0F2FF0BEC860Q40086170-DE898DB6-899B-4939-AF10-1689B2ADDFABQ48140576-0FCC2600-13D3-403B-B322-5778D4A4CF00Q51052660-3B38BFDA-AEEE-490B-AF8F-4BDC734BEDB5Q51684688-949BA5DE-72EB-41C9-8989-39C89EA34ECBQ54980939-D7694EE5-7E03-48B1-91C2-83B79815C357
P2860
Postprandial hypertriglyceridemia and cardiovascular disease: current and future therapies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Postprandial hypertriglyceride ...... current and future therapies.
@en
type
label
Postprandial hypertriglyceride ...... current and future therapies.
@en
prefLabel
Postprandial hypertriglyceride ...... current and future therapies.
@en
P2860
P50
P1476
Postprandial hypertriglyceride ...... : current and future therapies
@en
P2093
P2860
P2888
P356
10.1007/S11883-013-0309-9
P577
2013-03-01T00:00:00Z
P6179
1003123247